Page last updated: 2024-08-16

ribavirin and Lymphoma, B-Cell, Marginal Zone

ribavirin has been researched along with Lymphoma, B-Cell, Marginal Zone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coskun, A; Karaoglu, AO; Yukselen, O; Yukselen, V1
Brault, P; Klotz, C; Mallet, V; Pol, S; Sultanik, P1
Alric, L; Besson, C; Bonnet, D; Cacoub, P; Canioni, D; Davi, F; Hermine, O; Jeannel, J; Lapidus, N; Michot, JM; Pol, S; Rabiega, P; Ysebaert, L1
Arcaini, L; Bruno, R1
Brandimarte, G; Torello, M; Tursi, A1
Andreadis, C; Downs, LH; Miller, WT; Schuster, SJ; Svoboda, J; Tsai, DE1

Reviews

2 review(s) available for ribavirin and Lymphoma, B-Cell, Marginal Zone

ArticleYear
Lacrimal gland marginal zone lymphoma: regression after treatment of chronic hepatitis C virus infection: case report and review of the literature.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:23

    Topics: Adult; Antiviral Agents; Eye Neoplasms; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lacrimal Apparatus; Lymphoma, B-Cell, Marginal Zone; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Ribavirin; Tomography, X-Ray Computed

2013
Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas.
    Current clinical pharmacology, 2010, Volume: 5, Issue:2

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell, Marginal Zone; Ribavirin

2010

Trials

1 trial(s) available for ribavirin and Lymphoma, B-Cell, Marginal Zone

ArticleYear
Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy.
    Journal of clinical gastroenterology, 2004, Volume: 38, Issue:4

    Topics: Adult; Aged; Antiviral Agents; Female; Gastric Mucosa; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome

2004

Other Studies

3 other study(ies) available for ribavirin and Lymphoma, B-Cell, Marginal Zone

ArticleYear
Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment.
    Blood, 2015, Apr-09, Volume: 125, Issue:15

    Topics: Antiviral Agents; Female; Hepacivirus; Hepatitis C; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Ribavirin; Sofosbuvir; Uridine Monophosphate

2015
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Proportional Hazards Models; Protease Inhibitors; Recombinant Proteins; Ribavirin; RNA, Viral; Survival Rate; Treatment Outcome

2016
Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:9

    Topics: Drug Therapy, Combination; Hepatitis C; Humans; Interferons; Liver Neoplasms; Lymphatic Metastasis; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Ribavirin; Salivary Gland Neoplasms

2005